ReviewIndian heart journal2014
Consensus statement on management of dyslipidemia in Indian subjects.
Open access · goldAbstract readReviewConsensus Statement
In one paragraph
Review in Indian heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.
- Content and quality of clinical practice guidelines for the management of type 2 diabetes in India: A systematic review.Endocrinology, diabetes & metabolism · 2023Pooled it
- Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - a randomized controlled, parallel arm study.Lipids in health and disease · 2017Trial
- Article
- Dyslipidaemia and cardiovascular risk - Key considerations in South Asians.Clinical medicine (London, England) · 2026Review
- Community-based evaluation of cardiovascular risk using QRISKBMC public health · 2025Article
- Level of medication non-adherence among ambulatory patients with dyslipidemia and comorbid illness in Northwest Ethiopia: a multicenter cross-sectional study.Therapeutic advances in chronic disease · 2025Article
- Expert Opinion on Targeted Lipid Control for Very-high-risk Indian Patients: Bridging the Gap in Real-world Practice.European cardiology · 2025Review
- Article
- Functionality and Health-Promoting Properties of Polysaccharide and Plant-Derived Substances fromFoods (Basel, Switzerland) · 2024Review
- Exercise and lipids.Indian heart journal · 2024Review
- Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.PLOS global public health · 2024Article
- Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease.Annals of cardiac anaesthesia · 2024Article
- Profile of type 2 diabetes mellitus patients attending family medicine clinic in a rural tribal locality in India.Journal of family medicine and primary care · 2023Article
- Quality of the Indian clinical practice guidelines for the management of cardiovascular conditions.JRSM open · 2022Article
- Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study.Diabetology & metabolic syndrome · 2022Article
- Effectiveness of Yoga Lifestyle on Lipid Metabolism in a Vulnerable Population-A Community Based Multicenter Randomized Controlled Trial.Medicines (Basel, Switzerland) · 2021Article
- Distribution of Lipids and Prevalence of Dyslipidemia among Indian Expatriates in Qatar.Journal of lipids · 2021Article
- Current Practices and Gaps in Management of Dyslipidemia in Type 2 Diabetes Mellitus (T2DM) in Accordance with American Diabetes Association (ADA) Guidelines: A Subset Analysis from a Real-World, Cross-Sectional Observational Study (LEADD Study).Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Effects of Lipids and Lipoproteins on Mesenchymal Stem Cells Used in Cardiac Tissue Regeneration.International journal of molecular sciences · 2020Review
- Lipids in South Asians: Epidemiology and Management.Current cardiovascular risk reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 13 institutions in 1 country.
K Sarat ChandraEditor, Indian Heart Journal, Sr. Cardiologist, Indo US Superspeciality Hospital, Ameerpet, Hyderabad 500016, India.
Manish BansalSenior Consultant e Cardiology, Medanta e The Medicity, Sector 38, Gurgaon, Haryana 122001, India.
Tiny NairHead, Department of Cardiology, PRS Hospital, Trivandrum, Akashdeep, TC 17/881, Poojapura, Trivandrum, Kerala 695012, India.
S S IyengarSr. Consultant & HOD, Manipal Hospital, 133, JalaVayu Towers, NGEF Layout, Indira Nagar, Bangalore 560038, India.
Rajeev GuptaHead of Medicine and Director Research, Fortis Escorts Hospital, JLN Marg, Malviya Nagar, Jaipur 302017, India.
Subhash C ManchandaSr. Cardiologist, Sir Ganga Ram Hospital, New Delhi, India.
P P MohananWestfort H. Hospital, Poonkunnanm, Thrissur 680002, India.
V Dayasagar RaoSr. Cardiologist, Krishna Institute of Medical Science, Minister Road, Secunderabad, India.
C N ManjunathDirector, Prof & HOD, Sri Jayadeva Institute of Cardiovascular Sciences & Research, Bannerghatta Road, Bangalore 560 069, India.
J P S SawhneyMD DM FACC, Chairman Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, India.
Nakul SinhaSr. Consultant & Chief Interventional Cardiologist, Sahara India Medical Institute, VirajKhand, Gomti Nagar, Lucknow, Uttar Pradesh 226010, India.
A K PancholiaHead, Department of Clinical and Preventive Cardiology and Research Centre Arihant Hospital, Indore, MP, India.
Sundeep MishraProf. of Cardiology, All India Institute of Medical Sciences, New Delhi 110029, India.
Ravi R KasliwalChairman, Clinical and Preventive Cardiology, Medanta e The Medicity, Sector 38, Gurgaon, Haryana 122001, India.
Saumitra KumarProfessor, Vivekanada Institute of Medical Sciences, Kolkata, India; Chief Co-ordinator, Academic Services (Cardiology), Narayana Hrudayalay, RTIICS, Kolkata, India; Consultant Cardiologist, Fortis Hospital, Kolkata, India.
Unni KrishnanChief Endocrinologist & CEO, Chellaram Diabetes Institute, Pune 411021, India.
Sanjay KalraConsultant Endocrinology, Bharti Hospital & BRIDE, Karnal, Haryana, India.
Anoop MisraChairman, Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, New Delhi, India.
Usha ShrivastavaHead, Public Health, National Diabetes, Obesity and Cholesterol Foundation (N-DOC), Diabetes Foundation (India), New Delhi, India.
Seema GulatiHead, Nutrition Research Group, Center for Nutrition & Metabolic Research (C-NET) & National Diabetes, Obesity and Cholesterol Foundation (N-DOC), New Delhi, India; Chief Project Officer, Diabetes Foundation (India), C-6/57, Safdarjung Development Area, New Delhi 110 016, India.
Medanta The Medicity · INNational Diabetes Obesity and Cholesterol Foundation · INSir Ganga Ram Hospital · INAll India Institute of Medical Sciences · INBharti Hospital · INFortis Escorts Hospital · INIndo-US Super Speciality Hospital · INKrishna Institute of Medical Sciences · INManipal Hospital · INNarayana Health · INParas Hospitals · INSahara Hospital · INSri Jayadeva Institute of Cardiovascular Sciences and Research · IN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
ConsensusDisease ManagementDyslipidemiasHumansIndiaMorbidity
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.